Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
iasar
eg s.p.a. - ciprofloxacina - ciprofloxacina
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
rosuvastatina teva
teva italia s.r.l. - rosuvastatina - rosuvastatina
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
miastina
i.b.n. savio s.r.l - rosuvastatina - rosuvastatina
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
rosuvastatina eg
eg s.p.a. - rosuvastatina - rosuvastatina
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
rosuvastatina zentiva
zentiva italia s.r.l. - rosuvastatina - rosuvastatina
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
rosuvastatina sandoz
sandoz s.p.a. - rosuvastatina - rosuvastatina
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
rosuvastatina almus
almus s.r.l. - rosuvastatina - rosuvastatina
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
dilivas
doc generici srl - rosuvastatina - rosuvastatina
Evrópusambandið -
ítalska -
EMA (European Medicines Agency)
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustina - hodgkin disease; lymphoma, non-hodgkin - agenti antineoplastici - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
Ítalía -
ítalska -
AIFA (Agenzia Italiana del Farmaco)
rosuvastatina teva italia
teva italia s.r.l. - rosuvastatina - rosuvastatina